JD Health International Inc. (JDHIY)
JD Health International Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Beijing, BE, CN. The stock last traded at $5.05, up 0.00% on the session, giving a market capitalisation of $16.22B. On trailing twelve-month figures it carries a trailing P/E of 15.61, a net margin of 7.9%. Its beta of 1.18 implies it has historically moved more than the broad market.
JD Health International Inc., an investment holding firm, oversees an internet-based healthcare platform across the People's Republic of China. The company supplies a comprehensive range of pharmaceutical and health-related products, including over-the-counter and prescription medications, various medical equipment and supplies, along with health supplements and restorative tonics. These are distributed both through direct sales and an extensive online retail pharmacy network. Furthermore, JD Health provides an array of digital healthcare services such as virtual consultations, physician and hospital referrals, preventive health check-ups, genetic analysis, and aesthetic care. It also develops health management and intelligent healthcare technologies, in addition to offering technical and advertising services. The platform also enables access to external medical services, including full medical examinations, cosmetic medical treatments, vaccination appointment scheduling, dental care, and nucleic acid testing. Incorporated in 2018, the company is headquartered in Beijing, China, and functions as a subsidiary of JD Jiankang Limited.
JD Health International Inc. is most often compared with the following Healthcare names: